Regulatory Information

RanQ Excipients are manufactured under rigorous manufacturing conditions, which include stringent in-process controls and monitoring of critical process parameters to ensure compendial compliance and Excipients with high quality standards and consistent performance.

To maintain quality standards, RanQ has well defined quality procedures and systems in place in compliance with the requirements of the Current Good Manufacturing Practices (cGMP), WHO-GMP, ICH Q7 and IPEC. This ensures that our operating procedures meet the standards of all regulators.

All of RanQ’s Products are manufactured in accordance to the International Good Manufacturing Practices and Comply with the most used official compendiums such as:

  • United States Pharmacopoeia (USP-NF)
  • British Pharmacopoeia (BP)
  • European Pharmacopoeia (EP)
  • Indian Pharmacopoeia (IP)